Adamian L V, Fanchenko N D, Andreeva E N, Novikov E A, Alekseeva M L
Sov Med. 1990(6):26-9.
CA-125 antigen was assayed in 108 patients with the most prevalent gynecologic diseases by enzyme immunoassay. Its blood levels were found to be under 35 U/ml in the patients with inflammatory diseases. In endometriosis and benign ovarian tumors CA-125 concentrations in the blood were elevated. Malignant tumors of the ovaries were detected in 80 percent of the examinees. CA-125 levels reduced after surgical treatment in 72 percent of patients. These data permit a conclusion that CA-125 diagnostic agent may be used to monitor the course of the postoperative period and assess the late results of treatment.
采用酶免疫分析法对108例患有最常见妇科疾病的患者进行了CA - 125抗原检测。发现炎症性疾病患者的血液水平低于35 U/ml。子宫内膜异位症和卵巢良性肿瘤患者血液中的CA - 125浓度升高。80%的受检者检测出卵巢恶性肿瘤。72%的患者术后CA - 125水平下降。这些数据可以得出结论，CA - 125诊断剂可用于监测术后病程并评估治疗的远期效果。
